Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Other Non-Current Liabilities (2020 - 2025)

Maxcyte (MXCT) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $25000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 90.97% to $25000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $25000.0, a 90.97% decrease, with the full-year FY2024 number at $274000.0, down 3.18% from a year prior.
  • Other Non-Current Liabilities was $25000.0 for Q3 2025 at Maxcyte, down from $248000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.3 million in Q4 2022 to a low of $25000.0 in Q3 2025.
  • A 5-year average of $599864.7 and a median of $393000.0 in 2022 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: skyrocketed 232.93% in 2023, then tumbled 90.97% in 2025.
  • Maxcyte's Other Non-Current Liabilities stood at $450200.0 in 2021, then soared by 193.2% to $1.3 million in 2022, then crashed by 78.56% to $283000.0 in 2023, then fell by 3.18% to $274000.0 in 2024, then crashed by 90.88% to $25000.0 in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Other Non-Current Liabilities are $25000.0 (Q3 2025), $248000.0 (Q2 2025), and $270000.0 (Q1 2025).